Targeted radiation shows promise for recurrent gynecologic cancers
NCT ID NCT03325634
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This early-phase study tested a precise type of radiation called stereotactic body radiation therapy (SBRT) in 15 women with ovarian or uterine cancer that had come back in a limited area. The goal was to find the safest dose and see how well it controls tumor growth. Researchers focused on side effects and tumor response, offering a potential option for patients with few recurrence spots.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT FALLOPIAN TUBE CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado Hospital
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.